Axel Johnson investment fund Novax co-led a $15.3m round for Fraunhofer Institute's vegan protein and dairy substitute developer.
Prolupin, a Germany-based plant-derived food products supplier founded on research from Fraunhofer Institute for Process Engineering and Packaging, has raised €14m ($15.3m) in a funding round co-led by Novax, an investment vehicle for conglomerate Axel Johnson.
Investment firm Capricorn Partners co-led the round through its Sustainable Chemistry Fund while venture capital firms Munich Venture Partners and eCapital also took part.
Founded in 2010, Prolupin has developed a vegan protein alternative sourced from sweet lupine that is used in…
